However, this study, along with previous studies, has proved that obesity is a manageable risk factor of diabetes and that weight loss medications are highly recommended for diabetic patients to reduce fat deposition on insulin receptors and to prevent or treat the condition of insulin resistance that is highly prevalent in diabetic patients. Here, INSR is linked to obesity due to melanocortin 4 receptor deficiency.